Preemptive Resuscitation for Eradication of Septic Shock
Preemptive Empiric Resuscitation Protocol for the Prevention of Disease Progression in the Treatment of Sepsis
1 other identifier
interventional
142
1 country
5
Brief Summary
The purpose of this study is to assess the ability of an empiric resuscitation strategy compared to standard care to decrease the incidence of organ failure in normotensive sepsis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable sepsis
Started Sep 2011
Longer than P75 for not_applicable sepsis
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
September 29, 2011
CompletedFirst Posted
Study publicly available on registry
October 10, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedResults Posted
Study results publicly available
October 4, 2017
CompletedOctober 4, 2017
October 1, 2017
3.3 years
September 29, 2011
November 30, 2016
October 2, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With Worsening Organ System Dysfunction Defined by SOFA Score Increase ≥ 1
Development of worsening organ failure defined by the Sequential Organ Failure Assessment (SOFA) score. The SOFA score defines the presence and severity of dysfunction within 6 organ systems (cardiovascular, respiratory, coagulation, liver, renal, and nervous system) with a value of "0" for assigned to normal function to a maximum value of "4" for severe dysfunction in each of the organ systems. Each component of the SOFA score is added together, ranging from "0" indicating no organ dysfunction in any of the 6 organ systems, to "24" indicating maximal organ dysfunction across all 6 organ systems. Within this trial, the occurrence of organ failure was defined by any increase in the total SOFA score by ≥ 1 point over the first 72 hours after randomization.
72 hours
Secondary Outcomes (2)
In-hospital Mortality
In-hospital discharge or up to maximum 30 days
Number of Participants With Experiencing Complications Related to Intravascular Volume Overload
12 hours following treatment initiation
Study Arms (2)
Control
NO INTERVENTIONStandard medical care by the primary treatment team.
Interventional arm
EXPERIMENTALProtocolized empiric resuscitation delivering weight-based intravenous fluid resuscitation targeting lactate normalization
Interventions
0.9% Sodium chloride intravenous fluid
Eligibility Criteria
You may qualify if:
- Emergency department patient with suspected or confirmed infection as primary reason for admission
- Serum venous lactate 2.0 - 3.9 mmol/L
- Hospital admission planned
You may not qualify if:
- Age \< 18 years
- Pregnancy
- Serum lactate ≥ 4.0 mmol/L
- Any vasopressor or inotrope requirement
- Mechanical ventilation or non-invasive positive pressure ventilation
- Chronic end-stage renal disease requiring hemodialysis
- Pulmonary edema as diagnosed by the primary care team
- Requirement for surgery within the treatment protocol timeframe
- Inability to obtain informed consent from subject or surrogate
- Patient to receive comfort measures only
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Christiana Care Health System
Newark, Delaware, 19718, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Detroit Receiving Hospital/University Health Center
Detroit, Michigan, 48201, United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
Cooper University Hospital:Cooper Medical School of Rowan University
Camden, New Jersey, 08103, United States
Related Publications (3)
Sakr Y, Vincent JL, Schuerholz T, Filipescu D, Romain A, Hjelmqvist H, Reinhart K. Early- versus late-onset shock in European intensive care units. Shock. 2007 Dec;28(6):636-643.
PMID: 18092378BACKGROUNDMikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, Bellamy SL, Christie JD. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med. 2009 May;37(5):1670-7. doi: 10.1097/CCM.0b013e31819fcf68.
PMID: 19325467BACKGROUNDGlickman SW, Cairns CB, Otero RM, Woods CW, Tsalik EL, Langley RJ, van Velkinburgh JC, Park LP, Glickman LT, Fowler VG Jr, Kingsmore SF, Rivers EP. Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. Acad Emerg Med. 2010 Apr;17(4):383-90. doi: 10.1111/j.1553-2712.2010.00664.x.
PMID: 20370777BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Ryan Arnold, MD, Director of Research, Emergency Medicine
- Organization
- Christiana Care Health System
Study Officials
- STUDY CHAIR
Alan Jones, MD
University of Mississippi Medical Center
- PRINCIPAL INVESTIGATOR
Ryan Arnold, MD
Cooper University Hospital: Cooper Medical School of Rowan University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2011
First Posted
October 10, 2011
Study Start
September 1, 2011
Primary Completion
January 1, 2015
Study Completion
January 1, 2016
Last Updated
October 4, 2017
Results First Posted
October 4, 2017
Record last verified: 2017-10